Avingtrans plc
Avingtrans plc

Avingtrans plc share price, company news, analysis and interviews

Avingtrans plc (LON:AVG) has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. Significant shareholder value is delivered through a clear strategy, a strong balance sheet and an agile and experienced management team.

ADVANCED ENGINEERING SYSTEMS (AES) DIVISION

A highly-skilled engineering workforce for the design, manufacture, integration and servicing of an extensive product portfolio including specialist motors, pumps, turbines, compressors, pressure vessels and containers. Our performance-critical power, pump, process and storage solutions support energy systems operating in the most demanding and harshest of environments, onshore and offshore across the globe.

 
Avingtrans
Avingtrans

Hayward Tyler have unsurpassed experience and engineering know-how in the design, manufacture and servicing of performance critical fluid-filled electric motors and pumps for difficult to handle fluids and applications throughout the global energy sector.

Energy Steel has been serving the nuclear power industry since 1986 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services.

Avingtrans
Avingtrans

Slack & Parr has become a market leader in high precision engineering, supplying gear metering pumps and rotary flow dividers, across the UK and worldwide.

Metalcraft manufacture equipment for some of the world’s most hazardous environments, including being a leading authority on the manufacture of storage containers for radioactive nuclear waste.

Avingtrans
Avingtrans

Booth, based in Bolton, designs and manufactures blast doors and prefabricated fire and blast wall systems, fire doors (integrity and insulated) for both off and on-shore applications, radiation shielding doors, acoustic doors, security doors, multi-performance and large bespoke doors.

Omandy is a leading provider of heat exchange solutions for all commercial and industrial sectors. They offer a comprehensive range of products and solutions for the Building Services, Engineering and off-shore industries.

Avingtrans

With extensive experience in the composite industry, Composite Products Limited provides world class advanced composite components for global industries.

MEDICAL DIVISION

Our Medical and Industrial Imaging division (MII) is focused on becoming a leading player in the production of compact helium-free Magnetica Resonance Imaging (MRI) systems and 3D X-ray systems. This division has recently received FDA approval for its orthopaedic imaging system and is working on advancing complementary technologies in the field of Nuclear Magnetic Resonance (NMR).

Avingtrans
Avingtrans

Adaptix is transforming radiology by bringing to market an addressable Flat Panel X-ray Source (FPS) with a multitude of individually addressable emitters with integrated power supply (known as a ‘monoblock’) – essentially we are ‘digitizing’ the source to complete the digitization of the imaging system.

Magnetica specializes in engineering Next Generation MRI technologies. They design and develop MRI systems and components that unlock new market applications, enhance imaging capability, increase workflow efficiency, and provide greater patient comfort.

Avingtrans

Tecmag manufacture NMR, NQR & MRI instrumentation including nuclear magnetic resonance spectrometers and full consoles, system upgrades, and solid-state NMR / NQR probes.

Scientific Magnetics design, manufacture, test and install bespoke superconducting magnet systems and helium-free magnet systems for academic and commercial medical applications and research.

You can share this page with:

Avingtrans plc

Avingtrans plc share price

Fundamentals

52 Week High / Low

Avingtrans plc Results, Reports, Analysis and Insights

News

Interviews

Avingtrans Plc Building Momentum in Nuclear and Medical Imaging as Margins Surge (Video)

Avingtrans delivered improved margins and earnings in the first half, supported by stronger aftermarket activity and disciplined debt control. While revenue was flat year-on-year, management expects the usual second-half weighting to return, aided by nuclear contracts and rising data centre cooling demand. With Adaptix now FDA approved and US distributors appointed, medical imaging enters a critical commercial phase alongside growing exposure to AI-driven nuclear build-out.

Question & Answers

Analyst Notes & Comments

More Information

Latest Avingtrans plc News

Interviews

Questions & Answers

Broker Notes & Comments

Avingtrans plc share price

Fundamentals

52 Week High / Low

Share this page

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.